pediatric cancer

You have access
Nivolumab for the Treatment of Advanced Pediatric Malignancies
AGATA MARJAŃSKA, MONIKA DROGOSIEWICZ, BOŻENNA DEMBOWSKA-BAGIŃSKA, KATARZYNA PAWIŃSKA-WĄSIKOWSKA, WALENTYNA BALWIERZ, KATARZYNA BOBEFF, WOJCIECH MŁYNARSKI, AGNIESZKA MIZIA-MALARZ, ANNA RACIBORSKA, MARIUSZ WYSOCKI and JAN STYCZYŃSKI

Anticancer Research December 2020, 40 (12) 7095-7100; DOI: https://doi.org/10.21873/anticanres.14738
You have access
Feasibility and Immune Response of WT1 Peptide Vaccination in Combination with OK-432 for Paediatric Solid Tumors
KOICHI HIRABAYASHI, RYU YANAGISAWA, SHOJI SAITO, YUMIKO HIGUCHI, TERUTSUGU KOYA, KENJI SANO, SHIGEO KOIDO, MASATO OKAMOTO, HARUO SUGIYAMA, YOZO NAKAZAWA and SHIGETAKA SHIMODAIRA

Anticancer Research April 2018, 38 (4) 2227-2234;
You have access
Therapeutic Innovations for Targeting Childhood Neuroblastoma: Implications of the Neurokinin-1 Receptor System
MICHAEL BERGER and DIETRICH VON SCHWEINITZ

Anticancer Research November 2017, 37 (11) 5911-5918;
You have access
Vitamin D Receptor Polymorphism and Cancer: An Update
VIKRANT RAI, JOE ABDO, SWATI AGRAWAL and DEVENDRA K. AGRAWAL

Anticancer Research August 2017, 37 (8) 3991-4003;
You have access
Synergisitic and Antagonistic AML Cell Type-specific Responses to 5-Aza-2-deoxycitidine and 1-h-D-Arabinofuranoside
ABEER ABD ELMONEIM, ELISABETH HEUSTON, DANIEL H. WAI, TIMOTHY TRICHE and ROBERT J. ARCECI

Anticancer Research February 2016, 36 (2) 691-696;

Main menu